Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Lubaroff

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Urologia Internationalis|January 1, 1993
Localization of LAK cells and IL-2-stimulated regional lymph node lymphocytes by regional arterial infusion in renal tumor-bearing ratsM Hayakawa, D M Lubaroff, R D Williams, et al.
National Cancer Institute Monograph|December 1, 1978
An animal model for the study of prostate carcinomaD M Lubaroff, L Canfield, G T Rasmussen, et al.
Science (New York, N.Y.)|February 27, 1970
Mixed lymphocyte reactions and tissue transplantation toleranceW K Silvers, D M Lubaroff, D B Wilson, et al.
Journal of Immunogenetics|February 1, 1982
Genetic linkage and cell distribution analysis of T cell alloantigens in the ratD L Greiner, R W Barton, I Goldschneider, et al.
Transplantation Proceedings|June 1, 1981
A quantitative assay system for thymocyte regeneration in the ratD L Greiner, I Goldschneider, R W Barton, et al.
Hybridoma|October 1, 1987
Monoclonal antibodies to RT7 and LCA antigens in the rat: cell distribution and segregation analysisC F Mojcik, D L Greiner, I Goldschneider, et al.
Journal of the National Cancer Institute|June 1, 1977
R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostate cancerD M Lubaroff, L Canfield, T L Feldbush, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Characterization of monoclonal antibodies that define rat T cell alloantigensJ M Ely, D L Greiner, D M Lubaroff, et al.
The Prostate|January 1, 1985
Characterization of the heterogeneity of R3327 rat prostatic tumors derived from single-cell clonesS A Thompson, M P Johnson, P M Heidger, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 2011
Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODNS M Geary, C D Lemke, D M Lubaroff, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Urologia Internationalis|January 1, 1993
Localization of LAK cells and IL-2-stimulated regional lymph node lymphocytes by regional arterial infusion in renal tumor-bearing ratsM Hayakawa, D M Lubaroff, R D Williams, et al.
National Cancer Institute Monograph|December 1, 1978
An animal model for the study of prostate carcinomaD M Lubaroff, L Canfield, G T Rasmussen, et al.
Science (New York, N.Y.)|February 27, 1970
Mixed lymphocyte reactions and tissue transplantation toleranceW K Silvers, D M Lubaroff, D B Wilson, et al.
Journal of Immunogenetics|February 1, 1982
Genetic linkage and cell distribution analysis of T cell alloantigens in the ratD L Greiner, R W Barton, I Goldschneider, et al.
Transplantation Proceedings|June 1, 1981
A quantitative assay system for thymocyte regeneration in the ratD L Greiner, I Goldschneider, R W Barton, et al.
Hybridoma|October 1, 1987
Monoclonal antibodies to RT7 and LCA antigens in the rat: cell distribution and segregation analysisC F Mojcik, D L Greiner, I Goldschneider, et al.
Journal of the National Cancer Institute|June 1, 1977
R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostate cancerD M Lubaroff, L Canfield, T L Feldbush, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Characterization of monoclonal antibodies that define rat T cell alloantigensJ M Ely, D L Greiner, D M Lubaroff, et al.
The Prostate|January 1, 1985
Characterization of the heterogeneity of R3327 rat prostatic tumors derived from single-cell clonesS A Thompson, M P Johnson, P M Heidger, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 2011
Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODNS M Geary, C D Lemke, D M Lubaroff, et al.
Pageof 7